Overview

Neoadjuvant Paclitaxel Poliglumex, Cisplatin and Radiation for Esophageal Cancer: A Phase II Trial (CTI#X64001)

Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
Neoadjuvant Paclitaxel Poliglumex (PPX; CT-2103), Cisplatin and Radiation for Esophageal Cancer: A Phase II Trial. (CTI#X64001
Phase:
Phase 2
Details
Lead Sponsor:
Brown University
Collaborator:
University of Maryland Greenebaum Cancer Center
Treatments:
Albumin-Bound Paclitaxel
Cisplatin
Paclitaxel
Paclitaxel poliglumex